期刊文献+

P53、ras基因在肺腺癌组织中的表达及意义 被引量:2

Significance of P53 and ras expression in pulmonary adenocarcinoma
下载PDF
导出
摘要 目的 了解P5 3基因及ras基因在肺腺癌中的表达特点及与预后的关系。方法 采用免疫组化法对 5 3例肺腺癌组织中P5 3及ras蛋白进行检测 ,分组随访。结果 肺腺癌组织中P5 3、ras蛋白阳性表达率分别为 5 4.72 %、6 6 .38% ,淋巴结转移组阳性表达率 (78.13 %、84.38% )高于无淋巴结癌转移组 ;低分化者阳性表达率 (81.82 %、86 .36 % )高于高分化组 ;阴性组 1年存活率高于阳性组。结论 P5 3、ras表达和肺腺癌生物学行为有关 ,可作为判断预后的参考指标。 Objective To study the significance of p53 and ras expression in adenocarcinoma of the pulmonary.Methods Expression of p53 and ras in 53 cases of adenocarcinoma of the pulmonary was examined by immunohistochemistry.Results p53 protein was detected in 54.72% cases of pulmonary adenocarcinoma,ras protein was detected in 66.38% cases.Positive rate of p53 protein and ras protein was higher in the group of lymphatic metastasis and the group of poor differentiation than in the group of nolymphatic metastasis and the group of well differeniation.The 1 year survival rate of positive group of p53 protein and ras protein was lower than that of negative group.Conclusions p53 and ras were associated with malignant biological behavior and poor prognosis of pulmonary adenocarcinoma,which mya be potential prognostic factors in pulmonary adenocarcinoma. [
出处 《中国肿瘤临床与康复》 2000年第6期14-14,13,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 肺肿瘤 腺癌 P53 预后 免疫组织化学 lung neoplasms adenocarcinoma p53 ras prognosis immunohistochemistry
  • 相关文献

参考文献2

共引文献6

同被引文献21

  • 1侯振江.基因标志物在肺癌预后监测中的应用[J].临床肺科杂志,2004,9(6):668-669. 被引量:3
  • 2周彩存,易祥华,倪健,高文.环氧合酶2在非小细胞肺癌表达的临床意义[J].中华结核和呼吸杂志,2005,28(2):125-127. 被引量:4
  • 3Agorastos T, Lambropoulos AF, Constantindis TC, et al. P53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancert Prev, 2000,9(2):113-118.
  • 4Yuan A,Yu CJ,Luh KT,et al. Aberrant p53 expression correlates with expression of vascular endothelial growth factor and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol,2002,20(4) :900-910.
  • 5Hashimoto T,Kobayashi Y, Ishikawa Y,et al. Prognostic value of genetically diagnoses lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res, 2000,60(22) : 6472 - 6478.
  • 6Dworakwska D,Gozdz S,Jassem E,et al. Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-cell lung cancer. Lung Cancer,2002,35(1):35-41.
  • 7Zatsume T, Kobayashi M, Fujimoto S, et al. Association of p53 gene mutations with sensitivity to TZT-1027 in patients with clinical lung and renal carcinoma. Cancer, 2001,92 (2) : 386 - 394.
  • 8Altorki NK,Keresztes RS,Port JL,et al.Celecoxib,a selective cyclo-oxygenase-2 inhibitor,enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer[J].J Clin Oncol,2003,21 (14):2645-2650.
  • 9Schuler M,Herrmann R,De Greve JL,et al.Adenovirus mediated p53 gene transfer in patients receiving chemotherapy for advanced non small cell lung cancer:results of a multicenter phase Ⅱ study[J].J Clin Oncol,2001,19(6):1750-1758.
  • 10Niki T,Kohno T,Iba S,et al.Frequent co-localization of COX-2 and laminin-5 gamma 2 chain at the invasive front of early-stage lung adenocarcinomas[J].Am J Pathol,2002,160:1129-1141.

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部